Prevalence and risk factors for hypertension in hemophilia

Hypertension

Volumn 62, Issue 1, 2013, Pages 209-215

  Von Drygalski, Annette ^a,b   Kolaitis, Nicholas A ^a   Bettencourt, Ricki ^c   Bergstrom, Jaclyn ^c   Kruse Jarres, R ^d   Quon, Doris V ^e   Wassel, Christina ^c   Li, Ming C ^d   Waalen, Jill ^b   Elias, Darlene J ^b   Mosnier, Laurent O ^b   Allison, Matthew ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOINT REPLACEMENT INSTITUTE   (United States)

Author keywords

cardiovascular disease risk factors; hemophilia; hypertension; NHANES; prevalence

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEALTH CARE PERSONNEL; HEMOPHILIA; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

BP; CARDIOVASCULAR DISEASE RISK FACTORS; HEMOPHILIA; HYPERTENSION; NHANES; PREVALENCE;

ADULT; BLOOD PRESSURE; HEMOPHILIA A; HUMANS; HYPERTENSION; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84880740864     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01174     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention/Universal Data Collection Data Report 2011. Available at https://www2a.cdc.gov/ncbddd/htcweb/ UDC-Report/UDC-Report.asp. Accessed April 22, 2013.
2. Plug I, Van Der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede- Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost. 2006;4:510-516.
3. Rosendaal FR, Briët E, Stibbe J, van Herpen G, Leuven JA, Hofman A, Vandenbroucke JP. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol. 1990;75:525-530.
4. Srámek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet. 2003;362:351-354.
5. Chorba TL, Holman RC, Clarke MJ, Evatt BL. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Hematol. 2001;66:229-240.
6. Sharathkumar AA, Soucie JM, Trawinski B, Greist A, Shapiro AD. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia. 2011;17:597-604.
7. Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, Kolakoski M, Wilber N. Mortality among males with hemophilia: relations with source of medical care. Blood. 2000;96:437-442.
8. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008;140:378-384.
9. Witmer C, Presley R, Kulkarni R, Soucie JM, Manno CS, Raffini L. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. Br J Haematol. 2011;152:211-216.
10. Giroud M, Milan C, Beuriat P, Gras P, Essayagh E, Arveux P, Dumas R. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol. 1991;20:892-899.
11. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med. 1992;232:25-32.
12. Aronson DL. Cause of Death in Hemophilia-A Patients in the United- States from 1968 to 1979. Am J Hematol. 1988;27:7-12.
13. Darby SC, Kan SW, Spooner RJ, Giangrande PL, Hill FG, Hay CR, Lee CA, Ludlam CA, Williams M. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood. 2007;110:815-825.
14. Kim HC, Nam CM, Jee SH, Suh I. Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation study. Hypertension. 2005;46:393-397.
15. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
16. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet. 1998;352: 1801-1807.
17. Song YM, Sung J, Lawlor DA, Davey Smith G, Shin Y, Ebrahim S. Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study. BMJ. 2004;328:324-325.
18. Zanon E, Iorio A, Rocino A, et al.; Italian Association of Hemophilia Centers. Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia. 2012;18:39-45.
19. Biere-Rafi S, Baarslag MA, Peters M, Kruip MJ, Kraaijenhagen RA, Den Heijer M, Büller HR, Kamphuisen PW. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost. 2011;105:274-278.
20. Siboni SM, Mannucci PM, Gringeri A, Franchini M, Tagliaferri A, Ferretti M, Tradati FC, Santagostino E, von Mackensen S; Italian Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost. 2009;7:780-786.
21. Fransen van de Putte DE, Fischer K, Makris M, Tait RC, Collins PW, Meijer K, Roosendaal G, Chowdary P, Schutgens RE, Mauser-Bunschoten EP. Increased prevalence of hypertension in haemophilia patients. Thromb Haemost. 2012;108:750-755.
22. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(suppl 1):S11-S61.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
24. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716.
25. National Center for Health Statistics. Health, United States 2011. Hypertension among persons 20 years of age and over, by selected characteristics: United States, selected years 1988-1994 through 2007-2010. Library of Congress Catalog Number 76-641496, Table 70. 2011. Hyattsville, MD, Center for Disease Control and Prevention. Ref Type: Report
26. Bilora F, Zanon E, Petrobelli F, Cavraro M, Prandoni P, Pagnan A, Girolami A. Does hemophilia protect against atherosclerosis? A casecontrol study. Clin Appl Thromb Hemost. 2006;12:193-198.
27. Foley CJ, Nichols L, Jeong K, Moore CG, Ragni MV. Coronary atherosclerosis and cardiovascular mortality in hemophilia. J Thromb Haemost. 2010;8:208-211.
28. Walsh M, Macgregor D, Stuckless S, Barrett B, Kawaja M, Scully MF. Health-related quality of life in a cohort of adult patients with mild hemophilia A. J Thromb Haemost. 2008;6:755-761.
29. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, Imai Y, Ohkubo T, Kario K. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:203-208.
30. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999- 2010. JAMA. 2012;307:491-497.
31. Kahende JW, Adhikari B, Maurice E, Rock V, Malarcher A. Disparities in health care utilization by smoking status - NHANES 1999-2004. Int J Environ Res Public Health. 2009;6:1095-1106.
32. National Center for Health Statistics Health Data Interactive. http:// www.cdc.gov/nchs/hdi.htm. Diabetes, ages 20+, US, 1988-2010 (source:NHANES). Accessed January 28, 2013.
33. National Center for Health Statistics Health Data Interactive. Overweight/ Obesity, ages 20+:US, 1988-2010 (source:NHANES). http://www.cdc. gov/nchs/hdi.htm. Accessed January 28, 2013.
34. Saydah SH, Pavkov ME, Zhang C, Lacher DA, Eberhardt MS, Burrows NR, Narva AS, Eggers PW, Williams DE. Albuminuria prevalence in first morning void compared with previous random urine from adults in the national health and nutrition examination survey, 2009-2010. Clin Chem. 2013;59:675-683.
35. Keller SA, Moore CC, Clemens MG, McKillop IH, Huynh T. Activated protein C restores hepatic microcirculation during sepsis by modulating vasoregulator expression. Shock. 2011;36:361-369.
36. Koschinsky ML, Boffa MB, Nesheim ME, Zinman B, Hanley AJ, Harris SB, Cao H, Hegele RA. Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure. Clin Genet. 2001;60:345-349.
37. Małyszko J, Tymcio J. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension. Pol Arch Med Wewn. 2008;118:36-41.
38. Chalmers J, Todd A, Chapman N, Beilin L, Davis S, Donnan G, Frommer M, Huxley R, Lenfant C, MacMahon S, Mancia G, Mendis S, Whitworth J, Zanchetti A; International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens. 2003;21:651-663.
39. Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep. 2011;13:200-207. Society of Hematology